Britannia Life Sciences Inc (TSE:BLAB) has released an update.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Britannia Life Sciences Inc. has reported a revenue increase to $7.6 million and an adjusted EBITDA of $1.7 million for fiscal year 2024. The company also highlighted the strategic launch of its PhotonAssayTM units in Ontario and British Columbia, as well as a successful private placement raising $932,000, signaling expansion and technological advancements in mineral analysis.
For further insights into TSE:BLAB stock, check out TipRanks’ Stock Analysis page.